Private Client Services LLC acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 402 shares of the medical equipment provider’s stock, valued at approximately $210,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in ISRG. Godsey & Gibb Inc. raised its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the 3rd quarter worth about $33,000. Capital Performance Advisors LLP purchased a new position in Intuitive Surgical in the 3rd quarter worth about $38,000. DT Investment Partners LLC lifted its stake in Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after acquiring an additional 36 shares during the period. Finally, Mark Sheptoff Financial Planning LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $37,000. 83.64% of the stock is owned by institutional investors.
Insider Transactions at Intuitive Surgical
In other news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. This represents a 26.54 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.90% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
View Our Latest Report on Intuitive Surgical
Intuitive Surgical Stock Up 2.3 %
NASDAQ:ISRG opened at $544.02 on Thursday. The business’s 50-day simple moving average is $534.30 and its two-hundred day simple moving average is $493.26. Intuitive Surgical, Inc. has a 52 week low of $325.77 and a 52 week high of $556.23. The stock has a market cap of $193.77 billion, a PE ratio of 87.46, a P/E/G ratio of 5.31 and a beta of 1.39.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- Best Stocks Under $5.00
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Buy P&G Now, Before It Sets A New All-Time High
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Compound Interest and Why It Matters When Investing
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.